PF-04363467

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePF-04363467
Drug Alias Namedopamine D3-receptor antagonists (Pfizer)PF-04363467
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor antagonistsDopamine D2 receptor antagonists
TargetsDopamine D3 receptorDopamine D2 receptor
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksN/A